tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ROIV Stock Latest News

3 Stocks to Buy Now, According to the Technical Analysis
Market News3 Stocks to Buy Now, According to the Technical Analysis
8d ago
CXW
ACLX
Roivant Sciences Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Roivant Sciences Earnings Call: Progress Amid Challenges
16d ago
ROIV
Promising Potential of Roivant Sciences’ Brepocitinib and Pipeline Fuels Buy Rating
PremiumRatings
Promising Potential of Roivant Sciences’ Brepocitinib and Pipeline Fuels Buy Rating
17d ago
ROIV
Roivant Sciences Reports Q1 2025 Financial Results
PremiumCompany Announcements
Roivant Sciences Reports Q1 2025 Financial Results
17d ago
ROIV
Roivant Sciences reports Q1 EPS (33c), consensus (23c)
PremiumThe Fly
Roivant Sciences reports Q1 EPS (33c), consensus (23c)
18d ago
ROIV
Is ROIV a Buy, Before Earnings?
PremiumPre-EarningsIs ROIV a Buy, Before Earnings?
20d ago
ROIV
Roivant Sciences placed on ‘Positive Catalyst Watch’ at JPMorgan
Premium
The Fly
Roivant Sciences placed on ‘Positive Catalyst Watch’ at JPMorgan
1M ago
ROIV
Roivant Sciences resumed with a Buy at Goldman Sachs
Premium
The Fly
Roivant Sciences resumed with a Buy at Goldman Sachs
2M ago
ROIV
Roivant Sciences participates in a conference call with JPMorgan
PremiumThe Fly
Roivant Sciences participates in a conference call with JPMorgan
2M ago
ROIV
Roivant Sciences Announces $500M Share Repurchase Program
PremiumCompany Announcements
Roivant Sciences Announces $500M Share Repurchase Program
2M ago
8K
ROIV
Roivant Sciences announces $500M share repurchase program
PremiumThe Fly
Roivant Sciences announces $500M share repurchase program
2M ago
ROIV
Optimistic Outlook for Roivant Sciences: Buy Rating Backed by Brepo’s Potential and Financial Opportunities
PremiumRatings
Optimistic Outlook for Roivant Sciences: Buy Rating Backed by Brepo’s Potential and Financial Opportunities
2M ago
ROIV
Optimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
PremiumRatingsOptimistic Outlook for Roivant Sciences Driven by Promising Brepocitinib Results in Phase 3 VALOR Study
2M ago
ROIV
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
Premium
Ratings
Roivant Sciences’ Growth Potential Highlighted by Upcoming Phase 3 VALOR Study for Brepocitinib
2M ago
ROIV
JPMorgan positive on Roivant into dermatomyositis readout
Premium
The Fly
JPMorgan positive on Roivant into dermatomyositis readout
2M ago
ROIV
Roivant Sciences to hold an investor webinar
PremiumThe Fly
Roivant Sciences to hold an investor webinar
2M ago
ROIV
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
PremiumThe Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
2M ago
BA
BMY
Pulmovant announces publication of PK, lung deposition data for mosliciguat
PremiumThe Fly
Pulmovant announces publication of PK, lung deposition data for mosliciguat
2M ago
ROIV
Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
PremiumRatings
Strategic Growth and Orphan Drug Success Drive Buy Rating for Roivant Sciences
3M ago
ROIV
Roivant Sciences Reports Progress and Financial Results
PremiumCompany AnnouncementsRoivant Sciences Reports Progress and Financial Results
3M ago
ROIV
Roivant Sciences Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Roivant Sciences Earnings Call: Balancing Growth and Challenges
3M ago
ROIV
Roivant Sciences reports Q4 EPS (29c), consensus (16c)
Premium
The Fly
Roivant Sciences reports Q4 EPS (29c), consensus (16c)
3M ago
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >